X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/impact-of-baseline-dyskinesia-on-safety-and-efficacy-of-nourianz-istradefylline-in-patients-with-parkinsons-disease-presented-during-virtual-european-academy-of-neurology-meeting-301065566.html
https://www.prnewswire.com/news-releases/kyowa-kirin-announces-marketing-authorisation-application-for-istradefylline-validated-by-european-medicines-agency-300981075.html
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-hifibio-s-kite-backed-c-round-kyowa-kirin-s-parkinson-s-nod-relief-for
https://www.biospectrumasia.com/news/83/14350/fda-approves-new-add-on-drug-to-treat-parkinsons-disease.html
https://www.fiercepharma.com/pharma/spurned-by-fda-over-a-decade-ago-kyowa-kirin-nabs-nod-for-parkinson-s-drug
https://seekingalpha.com/news/3495099-fda-oks-kyowa-kirins-istradefylline-parkinsons
https://www.businesswire.com/news/home/20190404005252/en/Kyowa-Kirin-Announces-FDA-Acceptance-Istradefylline-KW-6002/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://www.fiercebiotech.com/biotech/after-seeing-poc-data-kyowo-advances-parkinson-s-program-despite-being-dropped-by-lundbeck?mkt_tok=eyJpIjoiTXpNd01HSm1OV1V5WkdKbCIsInQiOiJnblBvbFNseExoU1FyQXpGcjRlN0JZdHVQVVNtZVdmMk5zZFF1RTFUdTVwbUx1VUt4Q2ltMVo2SEltV252NlhkUmFvN0FOSU9YOGs4MUFKZ3BEY1NmR3Y1SDBmMnY1UWg2cTJta3lGR0UzY2RUWWw2XC95YUpSNHgrT001b3pJVUMifQ%3D%3D&mrkid=67302085
Market Place
Share 
